Innoviva
INVA
#5386
Rank
โ‚ฌ1.39 B
Marketcap
18,91ย โ‚ฌ
Share price
1.41%
Change (1 day)
13.87%
Change (1 year)

Earnings for Innoviva (INVA)

Earnings in 2026 (TTM): โ‚ฌ0.51 Billion

According to Innoviva's latest financial reports the company's current earnings are โ‚ฌ0.42 Billion. In 2025 the company made an earning of โ‚ฌ0.28 Billion, an increase over its 2024 earnings that were of โ‚ฌ32.77 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Innoviva from 2005 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) โ‚ฌ0.51 B79.28%
2025 โ‚ฌ0.28 B774.24%
2024 โ‚ฌ32.77 M-80.74%
2023 โ‚ฌ0.17 B-32.36%
2022 โ‚ฌ0.25 B-35.56%
2021 โ‚ฌ0.39 B25.7%
2020 โ‚ฌ0.31 B52.11%
2019 โ‚ฌ0.20 B10.77%
2018 โ‚ฌ0.18 B56.59%
2017 โ‚ฌ0.11 B125.53%
2016 โ‚ฌ52.18 M-417.36%
2015 -โ‚ฌ16.45 Million-74.49%
2014 -โ‚ฌ64.45 Million-25.19%
2013 -โ‚ฌ86.15 Million430.06%
2012 -โ‚ฌ16.26 Million-83.92%
2011 -โ‚ฌ0.11 Billion39.82%
2010 -โ‚ฌ72.31 Million2.84%
2009 -โ‚ฌ70.31 Million-8.62%
2008 -โ‚ฌ76.95 Million-47.92%
2007 -โ‚ฌ0.15 Billion-5.92%
2006 -โ‚ฌ0.16 Billion19.8%
2005 -โ‚ฌ0.14 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
OPKO Health
OPK
-โ‚ฌ0.21 Billion-138.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-โ‚ฌ15.92 Million-103.03%๐Ÿ‡บ๐Ÿ‡ธ USA